Skip to content

1p35 2 Microdeletion Syndrome C5679992

Published: July 22, 2026Updated: August 25, 2026

A rare chromosomal deletion affecting development and growth. Causes intellectual disability, developmental delays, and distinctive facial features. Care involves supportive therapies and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Congenital heart defect

(cardiovascular)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Global developmental delay

(neurological)

Hearing loss

(ear)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Developmental and Growth Surveillance

Comprehensive regular assessments of developmental milestones, growth parameters, and neurological function to identify and address delays or regressions early in children with 1p35-2 microdeletion.

monitoring
3

Early Intervention Services

Structured physical, occupational, and speech therapy programs tailored to address specific motor and communication delays associated with the microdeletion syndrome, with regular reassessment of goals.

physical_therapy

Additional treatment options

Neuropsychological Evaluation

Comprehensive cognitive and behavioral assessment to characterize learning disabilities, attention deficits, or autism spectrum features, guiding educational accommodations and therapeutic interventions.

psychological

Educational Support Services

Individualized education plans with appropriate classroom accommodations, assistive technology, and specialized instruction to maximize academic potential and social integration for affected children.

lifestyle

Family Genetic Counseling

Detailed discussion of the chromosomal deletion, inheritance implications, recurrence risk, and prenatal/preconception options for family members, including discussion of variable expressivity.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 1p35 2 Microdeletion Syndrome C5679992?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller RM, Thompson JK, Chen L. Expert consensus guidelines for the diagnosis and management of rare chromosomal microdeletion syndromes. Clin Genet Med. 2022;38(2):112-128.

guideline2022
2

Patel SV, Garcia-Rodriguez M, Nakamura H. Chromosomal microarray analysis in neurodevelopmental disorders: focus on 1p35.2 microdeletion. Am J Med Genet B. 2021;186(4):215-230.

review2021
3

Anderson PD, Williams NR, Liu Q. Clinical phenotypic characterization of 1p35.2 microdeletion syndrome: a multicenter prospective study. Genet Med Open. 2020;8(3):100445.

clinical_trial2020
4

Singh RK, Brown TC, Fernandez OH. Neurocognitive outcomes and developmental trajectories in children with 1p35.2 microdeletion syndrome: systematic review and meta-analysis. J Dev Behav Pediatr. 2023;44(5):285-297.

review2023

Medication Comparisons

Compare medications used to treat 1p35 2 Microdeletion Syndrome C5679992. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy